Navigation Links
Ace Biosciences, Ace393, the World's First Commercial Vaccine for,Travellers' Diarrhoea Caused by Campylobacter Successfully,Completes Phase I Clinical Trials

nnel recently deployed in the Middle East, 76% reported at least one episode of diarrhoea and more than 50% reported multiple episodes.

Current travel patterns suggest that in 2020 there will be about 190 million susceptible individuals travelling from significant economies to regions at risk of TD. Under current conditions, 20% - 90% of these individuals would be expected to develop TD within two weeks of arrival. Similar numbers of individuals are likely to visit regions at intermediate risk of TD and about 8 _ 20% of these individuals would be expected to develop TD.

Antibiotics are frequently prescribed to treat infection and anti-diarrhoeal agents are used to treat the symptoms, but at present there is no commercially available vaccine to address Campylobacter jejuni.

ACE BioSciences

ACE BioSciences is an emerging pharmaceutical company focused on developing novel protein-based vaccines and antibodies to address infectious diseases. It has unique expertise in the extraction and analysis of the cell surface proteins used by pathogens (eg bacteria, viruses and fungi) to interact with and infect human host cells. ACE BioSciences aims to develop a portfolio of products independently and in collaboration with other companies. In addition to ACE393, the company is working on a vaccine for Streptococcus pneumoniae, the bacterium responsible for Pneumococcal disease. The market for a Streptococcus product would be multibillion and ACE BioSciences aims to partner the project in the coming year. The company recently began work on a programme to address ETEC (enterotoxigeneic E coli), which is the primary cause of TD around the world.

In December 2005, ACE BioSciences announced a collaborative agreement with the Aeras Global TB Vaccine Foundation whereby ACE BioSciences will support the characterization of second-generation BCG-based tuberculosis (TB) vaccines under development by Aeras. In November 2005, ACE BioSciences and the Dutch bi
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Abbott Announces Positive Nine-Month Results From the Worlds First Clinical Trial of a Fully Bioabsorbable Drug Eluting Coronary Stent
2. Abbott Announces Positive Six-Month Results From the Worlds First Clinical Trial of a Fully Bioabsorbable Drug-Eluting Coronary Stent
3. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
4. Pixantrone Combination Therapy for First-line Treatment of Aggressive Non-Hodgkins Lymphoma Results in Reduction in Severe Toxicities Including Heart Damage When Compared to Doxorubicin-based Therapy
5. Genzyme Announces Data from First Phase 3 Study of Tolevamer in Patients with C. difficile Associated Diarrhea
6. Ablynx Announces Interim Results of First Nanobody Phase I Study of ALX-0081 (ANTI-VWF)
7. Advanced Life Sciences Announces Supplemental Efficacy Data from First Pivotal Phase 3 Pneumonia Clinical Trial
8. Advanced Life Sciences to Host Conference Call to Discuss Data From Cethromycins First of Two Phase 3 Pneumonia Trials
9. First Phase II Short-Term Study on Dapagliflozin Shows Results on Safety, Tolerability and Glycemic Markers in Subjects With Type 2 Diabetes
10. Advanced Cell Technology Develops First Human Embryonic Stem Cell Line without Destroying an Embryo
11. First Demonstration of nanoImmunology: a Nanomaterials-based Therapeutic Approach to Treat Allergy
Post Your Comments:
(Date:9/19/2014)... According to market research ... Industrial, & Laboratory), Industry (Food, Pharmaceutical, Biotechnology, Surgical ... & Geography - Global Trends & Forecast to ... lyophilization market on the basis of various types, ... the market size of each of these segments ...
(Date:9/19/2014)... ORLANDO, Fla. , Sept. 19, 2014 ... continues to grow, with the publication of two papers ... Otolaryngology – Head and Neck Surgery ... of both objective and subjective measures of sleep disordered ... therapy for the reduction in obstructive sleep apnea severity ...
(Date:9/19/2014)... and CAMBRIDGE, Mass. ... Inc. (PGDx), a provider of advanced cancer ... Medicines , a leader in discovering and developing ... today disclosed the first-ever comprehensive genomic study of ... deadly cancer of the female reproductive system, also ...
Breaking Medicine Technology:Lyophilization Market Worth $5,121.5 Million by 2019 2Lyophilization Market Worth $5,121.5 Million by 2019 3New Data shows Reductions in obstructive sleep apnea (OSA) severity and improvement of quality of life with Inspire therapy 2New Data shows Reductions in obstructive sleep apnea (OSA) severity and improvement of quality of life with Inspire therapy 3New Data shows Reductions in obstructive sleep apnea (OSA) severity and improvement of quality of life with Inspire therapy 4First Discovery Of Actionable Genetic Alterations In A Deadly Cancer Reported By Personal Genome Diagnostics And Blueprint Medicines 2First Discovery Of Actionable Genetic Alterations In A Deadly Cancer Reported By Personal Genome Diagnostics And Blueprint Medicines 3First Discovery Of Actionable Genetic Alterations In A Deadly Cancer Reported By Personal Genome Diagnostics And Blueprint Medicines 4
... Colo. , June 1 Encision Inc. (OTC ... technology that is emerging as a standard of care in ... purchasing agreement with HealthTrust Purchasing Group, LP ("HealthTrust"), effective ... are "Laparoscopic Safety Instruments – Active Electrode Monitoring Laparoscopy". , ...
... DURECT Corporation (Nasdaq: DRRX ) announced today that James E. Brown , ... Conference on Thursday, June 10 at 10:30 a.m. Eastern Time . ... .   , , , ... , , ...
Cached Medicine Technology:Encision and HealthTrust Purchasing Group Sign Purchasing Agreement 2DURECT to Present at the Jefferies Global Life Sciences Conference 2
(Date:9/21/2014)... Huntington, New York (PRWEB) September 21, 2014 ... release of their Risk Management Portal designed for ... applications with the intent to support effective risk ... is scheduled to go live coinciding with Waldorf’s ... September 21-24, 2014. , These applications were developed ...
(Date:9/21/2014)... September 21, 2014 "I wanted to ... having to consume sugary, foul-tasting energy drinks," said an ... always just want to drink plain, old coffee. That ... booster." , He developed ENERG CHEWING GUM to provide ... weight loss. The formula contains nutritious vitamins, minerals and ...
(Date:9/21/2014)... of Sparta. , Ancient Greek warriors were fed a ... of battle on distant fields. Cancer cells that metastasize ... study revealing previously unknown differences between cancer cells that ... those that travel to other organs. , Given that ... primary cause of cancer-related death, understanding how they successfully ...
(Date:9/21/2014)... 21, 2014 "I want to help ... back but haven’t the money for chiropractors," said an ... have such a product for myself." , The Stretch ... stretch the thigh muscles and align the spine properly. ... relieves discomfort of pinched nerves. Compact and easy to ...
(Date:9/21/2014)... September 21, 2014 The Electronic ... and supports electronic medical records (EMR) and electronic ... federal healthcare legislation during the past five years ... during the five years to 2019. The 2009 ... Act established Medicare and Medicaid incentives to encourage ...
Breaking Medicine News(10 mins):Health News:Waldorf Risk Solutions Releases New Risk Management Portal 2Health News:Cancer cells adapt energy needs to spread illness to other organs 2Health News:Electronic Medical Records Systems in the US Industry Market Research Report Now Available from IBISWorld 2Health News:Electronic Medical Records Systems in the US Industry Market Research Report Now Available from IBISWorld 3Health News:Electronic Medical Records Systems in the US Industry Market Research Report Now Available from IBISWorld 4
... consumption of ground beef or processed meat is positively associated ... 23 in the online journal PLoS ONE . ... University of California, San Francisco, also found that the correlation ... barbequed, especially when well done. They suggest that ...
... WEDNESDAY, Nov. 23 (HealthDay News) -- Tall or short, it,s ... person,s height. Now, scientists have found that short people actually ... them significantly smaller than average. Studying DNA from more ... learned that those of short stature -- defined roughly as ...
... Science Foundation (ESF) has awarded this year,s European Latsis ... Planck Institute for Demographic Research in Rostock, Germany. The ... was awarded the prize for his contributions to research ... demographic research. The Prize was awarded on the eve ...
... News) -- U.S. high school students still aren,t eating enough ... Centers for Disease Control and Prevention researchers. The investigators ... 12 who took part in the National Youth Physical Activity ... 1.2 times per day for both fruits and vegetables. ...
... variations in the numbers indicate that improvements are possible," says ... a study in Boston, USA, 234 million major surgical procedures ... of 25 human beings undergoes a major surgical procedure each ... also risky. According to the WHO, serious complications occur in ...
... 23 (HealthDay News) -- Huge meals and unhealthy foods, heavy ... and stroke over the holidays, an expert warns. For ... grams of fat, according to the American Council on Exercise. ... health consequences," Dr. Niten Singh, a member of the Society ...
Cached Medicine News:Health News:Gene Shortage Might Lead to Shorter Height, Study Says 2Health News:ESF awards 13th European Latsis Prize to James Vaupel on pioneering demographic research 2Health News:U.S. Teens Don't Eat Enough Fruits and Veggies: CDC 2Health News:Creating safer surgery to save more lives 2Health News:Creating safer surgery to save more lives 3
... The Lo-Profile™ tracheostomy tube is cosmetically ... ,Two styles of inner cannula come ... inner cannula and a 15 mm ... hook-up. The semi-reusable inner cannula may ...
Disposable Cannula Cuffless Tracheostomy Tubes...
Tube, tracheostomy, cuffed, size 8.0, SS, spiral reinforced PVC....
... KIMBERLY-CLARK BALLARD Adult ... designed for endotracheal intubated ... Features clear T-Piece, lavage/irrigation ... port. Offers multiple tracheostomy ...
Medicine Products: